Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Nov;92(11):1235-41.
doi: 10.1111/j.1349-7006.2001.tb02145.x.

Reversal of multidrug resistance by novel nitrophenyl pyrones, SNF4435C and D

K Kurosawa  1 , K Takahashi, E Tsuda, A Tomida, T Tsuruo
Affiliations

Reversal of multidrug resistance by novel nitrophenyl pyrones, SNF4435C and D

K Kurosawa et al. Jpn J Cancer Res. 2001 Nov.

Abstract

SNF4435C and D, novel immunosuppressants produced by a strain of Streptomyces spectabilis, were examined for their reversing effects in vitro on various multidrug-resistant (MDR) tumor cells overexpressing P-glycoprotein. These two compounds in the range of 3-10 microM completely reversed the resistance of MDR variant cells, mouse leukemia P388 cells [vincristine (VCR)-resistant P388/VCR and adriamycin (ADM)-resistant P388/ADM], human myelogenous leukemia K562 cells (VCR-resistant K562/VCR and ADM-resistant K562/ADM) and human ovarian cancer A2780 cells (ADM-resistant AD(10)), against VCR. Both compounds moderately potentiated the sensitivity of the MDR cells to ADM but the reversal was not complete. SNF4435C and D significantly increased the intracellular accumulation of VCR in AD(10) cells as potently as verapamil, cyclosporin A (CysA) and FK506, whereas the compounds exerted no effect on the accumulation of VCR in the drug-sensitive parent cells. Moreover, SNF4435C improved the chemotherapeutic efficacy of VCR in the treatment of P388/VCR-bearing mice. When 10 mg/kg SNF4435C was administered intraperitoneally to the mice concurrently with 0.2 mg/kg VCR for every 5 days, a treated/control (T/C) value of 143% was obtained. These results suggest that the compounds are useful candidates or tools for MDR modification in cancer chemotherapy.

PubMed Disclaimer

References

    1. ) Goldstein , L. J. , Galski , H. , Fojo , A. , Willingham , M. , Lai , S. L. , Gazdar , A. , Pirker , R. , Cossman , J. , Gottesman , M. M. and Pastan , I.Expression of a multidrug resistance gene in human cancers . J. Natl. Cancer Inst. , 81 , 116 – 124 ( 1989. ). - PubMed
    1. ) Roninson , I. B.The role of the MDR1 (P‐glycoprotein) gene in multidrug resistance in vitro and in vivo . Biochem. Pharmacol 43 , 95 – 102 ( 1992. ). - PubMed
    1. ) Germann , U. A.P‐Glycoprotein–a mediator of multidrug resistance in tumor cells . Eur. J. Cancer 32A , 927 – 944 ( 1996. ). - PubMed
    1. ) Tsuruo , T.Mechanisms of multidrug resistance and implications for therapy . Jpn. J. Cancer Res 79 , 285 – 296 ( 1988. ). - PMC - PubMed
    1. ) Endicott , J. A. and Ling , V.The biochemistry of P‐glyco‐protein‐mediated multidrug resistance . Annu. Rev. Biochem 58137 – 171 ( 1989. ). - PubMed

MeSH terms

Supplementary concepts

LinkOut - more resources